The first stock of Y-I medicine in China

LongFar was established in 1967, formerly known as Chuxiong Prefecture State-owned Pharmaceutical Factory and then bought by LongFar. Now, there are two standardized GMP factories in Kunming and Chuxiong city, with the largest monomer pharmaceutical workshop in Yunnan Province. Its annual production capacity covers: 1.5 billion capsules, one billion tablets, and 500 million bags of granules etc.

On April 27, 2017, LongFar landed National Equities Exchange and Quotations market, becoming the first public Yi minority medicine stock and leading the way of capital management of China’s Yi minority medicine.